Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

被引:0
|
作者
Anna Grenda
Ewelina Iwan
Izabela Chmielewska
Paweł Krawczyk
Aleksandra Giza
Arkadiusz Bomba
Małgorzata Frąk
Anna Rolska
Michał Szczyrek
Robert Kieszko
Tomasz Kucharczyk
Bożena Jarosz
Dariusz Wasyl
Janusz Milanowski
机构
[1] Medical University of Lublin,Department of Pneumonology, Oncology and Allergology
[2] National Veterinary Research Institute,Department of Omics Analyses
[3] Medical University of Lublin,Chair and Department of Neurosurgery and Pediatric Neurosurgery
来源
AMB Express | / 12卷
关键词
NSCLC; Response to immunotherapy; PD-1; PD-L1; Microbiome;
D O I
暂无
中图分类号
学科分类号
摘要
The significance of Akkermansia bacteria presence in gut micobiome, mainly Akkermansia mucinifila, is currently being investigated in the context of supporting therapy and marker for response to immunotherapy in cancer patients. It is indicated that patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) respond better to treatment if this bacterium is present in the intestine.
引用
收藏
相关论文
共 50 条
  • [1] Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
    Grenda, Anna
    Iwan, Ewelina
    Chmielewska, Izabela
    Krawczyk, Pawel
    Giza, Aleksandra
    Bomba, Arkadiusz
    Frak, Malgorzata
    Rolska, Anna
    Szczyrek, Michal
    Kieszko, Robert
    Kucharczyk, Tomasz
    Jarosz, Bozena
    Wasyl, Dariusz
    Milanowski, Janusz
    AMB EXPRESS, 2022, 12 (01)
  • [2] Gut microbes as medical signature for the effectiveness of immunotherapy in patients with advanced non-small cell lung cancer
    Adugna, Adane
    Muche, Yalew
    Jemal, Mohammed
    Habtegiorgis, Samuel Derbie
    Belew, Habtamu
    Azanaw Amare, Gashaw
    AGING MEDICINE, 2024, 7 (01) : 121 - 130
  • [3] Gut microbiome affects the response to immunotherapy in non-small cell lung cancer
    Ren, Shengnan
    Feng, Lingxin
    Liu, Haoran
    Mao, Yuke
    Yu, Zhuang
    THORACIC CANCER, 2024, 15 (14) : 1149 - 1163
  • [4] Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
    Sitthideatphaiboon, Piyada
    Somlaw, Nicha
    Zungsontiporn, Nicha
    Ouwongprayoon, Pongsakorn
    Sukswai, Narittee
    Korphaisarn, Krittiya
    Poungvarin, Naravat
    Aporntewan, Chatchawit
    Vinayanuwattikun, Chanida
    Hirankarn, Nattiya
    Chanida, Vinayanuwattikun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
    Liu, Ben
    Chau, Justin
    Dai, Qun
    Zhong, Cuncong
    Zhang, Jun
    CANCERS, 2022, 14 (21)
  • [6] Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
    Sitthideatphaiboon, Piyada
    Somlaw, Nicha
    Zungsontiporn, Nicha
    Ouwongprayoon, Pongsakorn
    Sukswai, Narittee
    Korphaisarn, Krittiya
    Poungvarin, Naravat
    Aporntewan, Chatchawit
    Hirankarn, Nattiya
    Vinayanuwattikun, Chanida
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 204 - 204
  • [7] Impact of intratumoral microbiome on immunotherapy treatment outcomes in patients with advanced non-small cell lung cancer
    Elkrief, A.
    Bowman, A.
    Rizvi, H.
    Hellmann, M.
    Riely, G. J.
    Schoenfeld, A. J.
    Ladanyi, M.
    Vanderbilt, C. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1037 - S1037
  • [8] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [9] The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
    Hakozaki, Taiki
    Richard, Corentin
    Elkrief, Arielle
    Hosomi, Yukio
    Benlaifaoui, Myriam
    Mimpen, Iris
    Terrisse, Safae
    Derosa, Lisa
    Zitvogel, Laurence
    Routy, Bertrand
    Okuma, Yusuke
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (10) : 1243 - 1250
  • [10] Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer
    Ge, X.
    Zhang, Z.
    Yan, X.
    Zhang, F.
    Yuan, F.
    Han, X.
    Huang, Z.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Zhi, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S641 - S642